Receptor-Dependent Growth Inhibition of Human Pancreatic Cancer by 9-cis Retinoic Acid

Journal of Gastrointestinal Surgery

Volumn 1, Issue 2, 1997, Pages 174-181

  Vickers, Selwyn M ^a,b   Sampson, L K ^a   Ying, W ^a   Phillips, J O ^a  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347304616     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(97)80106-0     Document Type: Article

References (22)

1. Lillimoe KD. Current management of pancreatic carcinoma, Ann Surg 1995;221:133-148.
2. McGuire GE, Pitt HA, Lillimoe KD, et al. Reoperative surgery for periampullary adenocarcinoma. Arch Surg 1991; 126:1205-1212.
3. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality and survival after the Whipple procedure. Ann Surg 1987;3:358-365.
4. Gudjonsson B. Carcinoma of the pancreas: Critical analysis of cost, results of resection and the need for standardized reporting. J Am Coll Surg 1995;181:483-503.
5. Pemrick SM, Lucas DA, Grippo JF. The retinoid receptors. Leukemia 1994;8 (Suppl 3):S1-S10.
6. Connie M, Agadir A, Degos L, Chomienne C. Retinoids and differentiation treatment: A strategy for treatment in cancer. Anticancer Res 1994;14:2339-2346.
7. Butler WB, Fontant JA. Responses to retinoic acid of tamoxifen-sensitive and resistant sublines of human breast cancer cell line MCF-7. Cancer Res 1992;52:6164-6167.
8. Eisenhauer EA, Lippman SM, Kavanagh JJ, et al. Combination 13-cis retinoic acid and interferon α 2 a in the therapy of solid tumors. Leukemia 1994;8:1622-1625.
9. Adamson PC. Clinical and pharmacokinetic studies of all-trans retinoic acid in pediatric patients with cancer. Leukemia 1994;8:1813-1816.
10. Houle B, Rochette-Egly C, Bradley WEC. Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 1993;90:985-989.
11. Chambon P. The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog Horm Res 1995; 50:317-332.
12. Berroden TJ, Marks MS, Ozato EL, et al. Heterodemerization among thyroid hormone receptor, retinoic acid receptor, retinoic X receptor, chicken ovalbumin upstream promoter transcription factor, and endogenous liver protein. Mol Endocrinol 1992;6:1468-1478.
13. Leid M, Kastner P, Lyons R, et al. Purification, cloning, and RXR identity of the Hela cell factor with which RAR or TR heterodimerizer to bind target sequence efficiently. Cell 1992;68:377-395.
14. Brand N, Petrovich M, Krust A, et al. Identification of a second human retinoic acid receptor. Nature 1988;332:850-853.
15. 3-activated expression of the rat osteocalan gene. Mol Cell Biol 1993;13:5907-5917.
16. Leid M, Kastner P, Chambon P. Multiplicity generates diversity in the retinoic acid signaling pathways. Trends Biol Sci 1992;17:427-433.
17. Heyman RA, Mangelsdorf DJ, Dyck JA, et al. 9-cis Retinoic acid is a high affinity ligand for the retinoic X receptor. Cell 1992;68:397-406.
18. Mundi JRF, Frankel SR, Huselton C, et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 1992;52:2138-2142.
19. Rosewicz S, Stier U, Brembeck F, et al. Retinoids: Effects of growth differentiation and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 1995;110:1646-1660.
20. Gigurre V. Retinoic acid receptors and cellular retinoic binding proteins: Complex interplay in retinoic signaling. Endocr Rev 1994;94:61-79.
21. Wei LN, Mertz JR, Goodman DS, et al. Cellular retinoic acid and cellular retinal-binding proteins: Complementary deoxyribonucleic acid cloning, chromasomal assignment and tissue specific expression. Mol Endocrinol 1987;1:526-534.
22. Libby PR, Bertram JS. Lack of intracellular binding proteins in a retinol-sensitive cell line. Carcinogenesis 1982;3:481-484.